or Try an Advanced Search...

    Nmda Receptor Antagonists Stocks List

    Symbol Grade Name % Change
    RLMD F Relmada Therapeutics, Inc. 0.67
    VTGN F VistaGen Therapeutics, Inc. -0.60
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Disease Antidepressants Biopharmaceutical Biotechnology Cartilage Chemical Entities Clinical Development Clinical Pharmacology Clinical Trial Depressive Disorder Disorders Drug Discovery Drug Metabolism Drug Rehabilitation Glutamate Health Sciences In Vitro Major Depressive Disorder Mental Health Metabolism

    Related ETFs - A few ETFs which own one or more of the above listed Nmda Receptor Antagonists stocks.

    Symbol Grade Name Weight
    PSIL F AdvisorShares Psychedelics ETF 4.92
    IBRN D iShares Neuroscience and Healthcare ETF 0.17
    IWC C iShares Microcap ETF 0.02
    AVSC C Avantis U.S. Small Cap Equity ETF 0.01
    DFAC A Dimensional U.S. Core Equity 2 ETF 0.0
    View all Nmda Receptor Antagonists ETFs...
    Compare ETFs
    Compare AVSC to DFAC Compare IBRN to AVSC Compare PSIL to IWC

        Nmda Receptor Antagonists Stocks Recent News

        Date Stock Title
        Jun 27 VTGN Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Disease Antidepressants Biopharmaceutical Biotechnology Cartilage Chemical Entities Clinical Development Clinical Pharmacology Clinical Trial Depressive Disorder Disorders Drug Discovery Drug Metabolism Drug Rehabilitation Glutamate Health Sciences In Vitro Major Depressive Disorder Mental Health Metabolism
        Nmda Receptor Antagonists

        NMDAR (N-methyl-D-aspartate receptor) antagonists are a class of drugs that block the activity of the NMDAR, a type of glutamate receptor found in the brain. These drugs are used to treat a variety of neurological and psychiatric disorders, including schizophrenia, bipolar disorder, and Alzheimer's disease. They are also being studied for their potential to treat other conditions, such as chronic pain and addiction.

        Browse All Tags